Table 3.
Biochemical changes following SWL (n = 12)
| Baseline | 30 min | 120 min | 240 min | Reference range | p value | Statistical test | |
|---|---|---|---|---|---|---|---|
| CRP (mg/L) | 3.1 (± 1.0/8.0) | 1.65 (± 1.0/7.0) | 1.8 (± 1.0/7.5) | 1.9 (± 1.0/6.40) | 0–5.0 | 0.101 | Friedman |
| Total protein (g/L) | 71.33 ± 4.83 | 67.93 ± 4.23* | 64.45 ± 3.45* | 67.64 ± 3.03* | 60.0–80.0 | < 0.001 | ANOVA |
| Albumin (g/L) | 43.13 ± 3.0 | 40.90 ± 3.12* | 39.33 ± 3.5* | 40.77 ± 3.22 | 35.0–45.0 | < 0.001 | ANOVA |
| Globulin (g/L) | 28 (± 25/37) | 28 (± 22/30) | 26 (± 23/27)* | 26.5 (± 25/30) | 23.0–35.0 | 0.006 | Friedman |
| Total bilirubin (µmol/L) | 13.5 (± 7/23) | 15 (± 7/22) | 12 (± 9/43) | 11 (± 8/22) | < 21 | 0.140 | Friedman |
| Alkaline phosphatase—ALP (U/L) | 73 (± 36/91) | 65 (± 37/93)* | 68.5 (± 35/85)* | 72.5 (± 34/86) | 30.0–130.0 | 0.018 | Friedman |
| Alkaline transaminase—ALT (U/L) | 35.5 (± 18/70) | 34 (± 18/65) | 35 (± 17/62) | 37 (± 15/67)* |
< 41 (male) < 33 (female) |
0.01 | Friedman |
| Urea (mmol/L) | 4.90 (± 2.7/6.0) | 4.80 (± 2.8/6.0) | 4.90 (± 3.6/5.20) | 4.85 (± 3.30/5.20) | 2.5–7.8 | 0.478 | Friedman |
| Creatinine (µmol/L) | 67.1 (± 11.39) | 69.7 (± 13.04) | 73.0 (± 12.30) | 71.1(± 14.09) |
M: 58.0–110.0 F: 46.0–92.0 |
0.365 | ANOVA |
| Sodium (mmol/L) | 140 (± 135/140) | 139 (± 132/143)* | 137 (± 134/142)* | 138 (± 133/140)* | 135.0–146.0 | 0.010 | Friedman |
| Potassium (mmol/L) | 4.27 (± 3.9/4.6) | 4.37 (± 3.64/4.60) | 4.12(± 3.4/5.0) | 4.2 (± 3.8/4.60) | 3.5–5.3 | 0.291 | Friedman |
Statistical significance following post hoc analysis is represented when *p ≤ 0.05. (M, male; F, female)